Wealthspring Capital’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-15,700
Closed -$161K – 180
2022
Q4
$161K Sell
15,700
-72,200
-82% -$734K 0.24% 139
2022
Q3
$884K Sell
87,900
-1,900
-2% -$19.1K 0.17% 205
2022
Q2
$902K Sell
89,800
-54,660
-38% -$550K 0.17% 210
2022
Q1
$1.46M Hold
144,460
– – 0.29% 111
2021
Q4
$1.47M Buy
+144,460
New +$1.46M 0.32% 112

Other funds holding IQMDU

Wealthspring Capital's IQMDU Position: Q1 2023 in Review

Wealthspring Capital sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2023, closing a stake of 15,700 shares — an estimated $161K sold.

Wealthspring Capital first reported a position in IQMDU in Q4 2021 and held it in 5 quarters. The position peaked at $1.47M in Q4 2021. 6 funds tracked by Wall St. Rank hold IQMDU as of Q1 2023.

  • Wealthspring Capital reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
  • Wealthspring Capital sold 15,700 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2023, an estimated $161K.
  • Wealthspring Capital first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
  • Wealthspring Capital's Intelligent Medicine Acquisition Corp. Unit position peaked at $1.47M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2023.

Based on Wealthspring Capital's 13F filing for Q1 2023, filed 25 Apr 2023.